CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Size-dependent activation of CAR-T cells.
Size-dependent activation of CAR-T cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
随着嵌合抗原受体(CAR)-T细胞的靶点扩展到多种癌症、自身免疫性疾病、病毒感染和纤维化,对识别新抗原和设计能够被有效激活的新型CAR的需求日益增加。
然而,抗原的合理选择和CAR的设计受到限制,原因在于对CAR如何被抗原激活的分子机制缺乏了解。在此,我们提供数据支持一种“尺寸排阻”模型,该模型解释了抗原信号如何跨质膜传递以激活CAR的胞内结构域。在该模型中,抗原与CAR结合导致形成狭窄的膜间隙,该间隙在物理上将CD45——一种体积较大的磷酸酶——排除在CAR区域之外,从而有利于激酶对CAR的磷酸化,进而触发下游通路导致T细胞激活。与该模型一致,增大CAR胞外结构域的尺寸在体外和小鼠淋巴瘤模型中均削弱了CAR-T 的激活;膜近端表位比膜远端表位更好地激活CAR-T。
此外,通过抗体偶联增大CD45的尺寸增强了识别膜远端表位的CAR的激活。一致地,表达较大异构体CD45RABC的CAR-T 比表达较小异构体CD45RO的CAR-T 被激活到更高水平。
总之,我们的工作揭示了CAR-T 激活取决于CAR-抗原对与CD45之间的尺寸差异;CAR、抗原和CD45的尺寸因此可以作为调节CAR-T 激活的靶点。
As the targets of chimeric antigen receptor (CAR)-T cells expand to a variety of cancers, autoimmune diseases, viral infections, and fibrosis, there is an increasing demand for identifying new antigens and designing new CARs that can be effectively activated.
However, the rational selection of antigens and the design of CARs are limited by a lack of knowledge regarding the molecular mechanism by which CARs are activated by antigens.
Here, we present data supporting a "size exclusion" model explaining how antigen signals are transmitted across the plasma membrane to activate the intracellular domains of CARs. In this model, antigen engagement with CAR results in a narrow intermembrane space that physically excludes CD45, a bulky phosphatase, out of the CAR zone, thus favoring CAR phosphorylation by kinases, which further triggers downstream pathways leading to T cell activation.
Aligned with this model, increasing the size of CAR extracellular domains diminished CAR-T activation both in vitro and in a mouse lymphoma model; membrane-proximal epitopes activated CAR-Ts better than membrane-distal epitopes.
Moreover, increasing the size of CD45 by antibody conjugation enhanced the activation of CARs that recognize membrane-distal epitopes. Consistently, CAR-Ts expressing CD45RABC, the larger isoform, were activated to a higher level than those expressing a smaller isoform CD45RO.
Together, our work revealed that CAR-T activation depends on the size difference between the CAR-antigen pair and CD45; the size of CAR, antigen, and CD45 can thus be targets for tuning CAR-T activation.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。